Agilent Technologies, Inc. (A)
USD 108.63
(2.04%)
USD 108.63
(2.04%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.03 Billion USD | -0.67% |
| 2022 | 1.03 Billion USD | 25.06% |
| 2021 | 830 Million USD | 15.28% |
| 2020 | 720 Million USD | 6.04% |
| 2019 | 679 Million USD | 6.43% |
| 2018 | 638 Million USD | 10.96% |
| 2017 | 575 Million USD | 7.88% |
| 2016 | 533 Million USD | -1.48% |
| 2015 | 541 Million USD | -49.53% |
| 2014 | 1.07 Billion USD | 0.56% |
| 2013 | 1.06 Billion USD | 5.13% |
| 2012 | 1.01 Billion USD | 12.92% |
| 2011 | 898 Million USD | 25.42% |
| 2010 | 716 Million USD | 29.71% |
| 2009 | 552 Million USD | -14.55% |
| 2008 | 646 Million USD | 0.47% |
| 2007 | 643 Million USD | 2.55% |
| 2006 | 627 Million USD | -13.16% |
| 2005 | 722 Million USD | -29.63% |
| 2004 | 1.02 Billion USD | 3.12% |
| 2003 | 995 Million USD | -15.96% |
| 2002 | 1.18 Billion USD | -20.59% |
| 2001 | 1.49 Billion USD | -19.54% |
| 2000 | 1.85 Billion USD | 23.62% |
| 1999 | 1.49 Billion USD | 0.94% |
| 1998 | 1.48 Billion USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1 Billion USD | -3.19% |
| 2024 Q3 | 978 Million USD | -2.2% |
| 2024 Q1 | 1.03 Billion USD | 0.19% |
| 2023 FY | 1.03 Billion USD | -0.67% |
| 2023 Q2 | 1.1 Billion USD | -0.72% |
| 2023 Q1 | 1.11 Billion USD | 7.03% |
| 2023 Q3 | 1.07 Billion USD | -2.81% |
| 2023 Q4 | 1.03 Billion USD | -3.82% |
| 2022 Q2 | 937 Million USD | 6.6% |
| 2022 Q1 | 879 Million USD | 5.9% |
| 2022 FY | 1.03 Billion USD | 25.06% |
| 2022 Q4 | 1.03 Billion USD | 2.77% |
| 2022 Q3 | 1.01 Billion USD | 7.79% |
| 2021 Q3 | 818 Million USD | 3.41% |
| 2021 Q2 | 791 Million USD | 4.77% |
| 2021 Q1 | 755 Million USD | 4.86% |
| 2021 Q4 | 830 Million USD | 1.47% |
| 2021 FY | 830 Million USD | 15.28% |
| 2020 Q2 | 750 Million USD | 6.23% |
| 2020 Q3 | 746 Million USD | -0.53% |
| 2020 Q4 | 720 Million USD | -3.49% |
| 2020 FY | 720 Million USD | 6.04% |
| 2020 Q1 | 706 Million USD | 3.98% |
| 2019 Q2 | 657 Million USD | 0.61% |
| 2019 Q1 | 653 Million USD | 2.35% |
| 2019 Q3 | 660 Million USD | 0.46% |
| 2019 Q4 | 679 Million USD | 2.88% |
| 2019 FY | 679 Million USD | 6.43% |
| 2018 Q2 | 594 Million USD | -2.3% |
| 2018 FY | 638 Million USD | 10.96% |
| 2018 Q4 | 638 Million USD | 2.41% |
| 2018 Q3 | 623 Million USD | 4.88% |
| 2018 Q1 | 608 Million USD | 5.74% |
| 2017 Q2 | 548 Million USD | -0.54% |
| 2017 Q3 | 566 Million USD | 3.28% |
| 2017 Q4 | 575 Million USD | 1.59% |
| 2017 FY | 575 Million USD | 7.88% |
| 2017 Q1 | 551 Million USD | 3.38% |
| 2016 Q1 | 554 Million USD | 2.4% |
| 2016 FY | 533 Million USD | -1.48% |
| 2016 Q3 | 543 Million USD | -2.16% |
| 2016 Q2 | 555 Million USD | 0.18% |
| 2016 Q4 | 533 Million USD | -1.84% |
| 2015 Q1 | 560 Million USD | -47.76% |
| 2015 Q3 | 545 Million USD | -1.98% |
| 2015 Q4 | 541 Million USD | -0.73% |
| 2015 FY | 541 Million USD | -49.53% |
| 2015 Q2 | 556 Million USD | -0.71% |
| 2014 Q3 | 1.09 Billion USD | -0.09% |
| 2014 Q1 | 1.08 Billion USD | 2.06% |
| 2014 FY | 1.07 Billion USD | 0.56% |
| 2014 Q2 | 1.1 Billion USD | 1.1% |
| 2014 Q4 | 1.07 Billion USD | -2.46% |
| 2013 Q3 | 1.05 Billion USD | 1.15% |
| 2013 Q4 | 1.06 Billion USD | 1.14% |
| 2013 FY | 1.06 Billion USD | 5.13% |
| 2013 Q2 | 1.04 Billion USD | 0.19% |
| 2013 Q1 | 1.04 Billion USD | 2.56% |
| 2012 Q1 | 937 Million USD | 4.34% |
| 2012 Q3 | 1.03 Billion USD | 9.4% |
| 2012 Q4 | 1.01 Billion USD | -2.12% |
| 2012 Q2 | 947 Million USD | 1.07% |
| 2012 FY | 1.01 Billion USD | 12.92% |
| 2011 FY | 898 Million USD | 25.42% |
| 2011 Q4 | 898 Million USD | 0.11% |
| 2011 Q3 | 897 Million USD | 5.16% |
| 2011 Q2 | 853 Million USD | 7.03% |
| 2011 Q1 | 797 Million USD | 11.31% |
| 2010 Q2 | 546 Million USD | -0.36% |
| 2010 Q1 | 548 Million USD | -0.72% |
| 2010 Q4 | 716 Million USD | 4.07% |
| 2010 Q3 | 688 Million USD | 26.01% |
| 2010 FY | 716 Million USD | 29.71% |
| 2009 Q1 | 655 Million USD | 1.39% |
| 2009 Q4 | 552 Million USD | -3.33% |
| 2009 Q2 | 608 Million USD | -7.18% |
| 2009 Q3 | 571 Million USD | -6.09% |
| 2009 FY | 552 Million USD | -14.55% |
| 2008 Q2 | 674 Million USD | 0.0% |
| 2008 Q4 | 646 Million USD | -4.15% |
| 2008 FY | 646 Million USD | 0.47% |
| 2008 Q1 | 674 Million USD | 4.82% |
| 2008 Q3 | 674 Million USD | 0.0% |
| 2007 Q2 | 650 Million USD | 0.31% |
| 2007 Q4 | 643 Million USD | -4.6% |
| 2007 Q1 | 648 Million USD | 3.35% |
| 2007 FY | 643 Million USD | 2.55% |
| 2007 Q3 | 674 Million USD | 3.69% |
| 2006 Q2 | 713 Million USD | -3.65% |
| 2006 FY | 627 Million USD | -13.16% |
| 2006 Q4 | 627 Million USD | -11.06% |
| 2006 Q3 | 705 Million USD | -1.12% |
| 2006 Q1 | 740 Million USD | 2.49% |
| 2005 Q3 | 936 Million USD | -2.3% |
| 2005 FY | 722 Million USD | -29.63% |
| 2005 Q2 | 958 Million USD | -7.62% |
| 2005 Q1 | 1.03 Billion USD | 1.07% |
| 2005 Q4 | 722 Million USD | -22.86% |
| 2004 FY | 1.02 Billion USD | 3.12% |
| 2004 Q2 | 1.05 Billion USD | -0.57% |
| 2004 Q3 | 1.06 Billion USD | 1.05% |
| 2004 Q4 | 1.02 Billion USD | -3.3% |
| 2004 Q1 | 1.05 Billion USD | 6.13% |
| 2003 Q3 | 1.05 Billion USD | -7.07% |
| 2003 Q4 | 995 Million USD | -5.33% |
| 2003 Q2 | 1.13 Billion USD | -3.0% |
| 2003 Q1 | 1.16 Billion USD | -1.52% |
| 2003 FY | 995 Million USD | -15.96% |
| 2002 FY | 1.18 Billion USD | -20.59% |
| 2002 Q1 | 1.38 Billion USD | -7.31% |
| 2002 Q2 | 1.3 Billion USD | -5.43% |
| 2002 Q3 | 1.3 Billion USD | -0.46% |
| 2002 Q4 | 1.18 Billion USD | -8.99% |
| 2001 Q4 | 1.49 Billion USD | -12.5% |
| 2001 Q3 | 1.7 Billion USD | -4.86% |
| 2001 Q2 | 1.79 Billion USD | -15.88% |
| 2001 FY | 1.49 Billion USD | -19.54% |
| 2001 Q1 | 2.12 Billion USD | 14.89% |
| 2000 Q2 | 1.62 Billion USD | 3.51% |
| 2000 Q1 | 1.56 Billion USD | 4.54% |
| 2000 FY | 1.85 Billion USD | 23.62% |
| 2000 Q4 | 1.85 Billion USD | 5.16% |
| 2000 Q3 | 1.76 Billion USD | 8.63% |
| 1999 Q4 | 1.49 Billion USD | 0.0% |
| 1999 FY | 1.49 Billion USD | 0.94% |
| 1998 FY | 1.48 Billion USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Charles River Laboratories International, Inc. | 380.25 Million USD | -171.131% |
| Quest Diagnostics Incorporated | 190 Million USD | -442.632% |
| Danaher Corporation | 2.59 Billion USD | 60.254% |
| Enzo Biochem, Inc. | 6.83 Million USD | -14990.749% |
| IQVIA Holdings Inc. | - USD | -Infinity% |
| Laboratory Corporation of America Holdings | 474.6 Million USD | -117.236% |
| Mettler-Toledo International Inc. | 385.86 Million USD | -167.192% |
| Qiagen N.V. | 398.38 Million USD | -158.795% |
| Revvity, Inc. | 428.06 Million USD | -140.853% |
| Thermo Fisher Scientific Inc. | 5.08 Billion USD | 79.737% |
| Waters Corporation | 516.23 Million USD | -99.715% |